Akso Health ratios data for the quarter ended Mar 2026. These financial ratios cover 26 quarters of results from Sep 2016 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Mar2020 | Sep2020 | Mar2021 | Sep2021 | Mar2022 | Sep2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||
| Gross Margin | 92.56% | 97.36% | 39.87% | -17.54% | 61.21% | 60.53% | 51.10% | |||||||||||||||||||
| EBT Margin | 70.35% | 70.78% | -465.25% | -521.56% | -56.39% | -133.23% | -207.82% | |||||||||||||||||||
| EBIT Margin | 69.75% | 69.88% | -481.96% | -582.97% | -57.92% | -156.61% | -226.40% | |||||||||||||||||||
| EBITDA Margin | 69.75% | 69.88% | -481.96% | -582.97% | -57.92% | -156.61% | -226.40% | |||||||||||||||||||
| Operating Margin | 69.75% | 69.88% | -481.96% | -582.97% | -57.92% | -156.61% | -226.40% | |||||||||||||||||||
| Net Margin | 74.11% | 57.87% | -605.30% | -512.50% | 179.34% | -145.58% | -316.52% | |||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||||||||||||||||
| Assets AverageAssets Avg. | 0.15B | 0.18B | 0.17B | 0.14B | 0.16B | 0.16B | 0.14B | 0.11B | 0.07B | 0.06B | 0.04B | 0.05B | 0.04B | 0.02B | 0.02B | 0.08B | 0.18B | 0.21B | 0.21B | 0.20B | ||||||
| Invested CapitalInvested Cap. | 14,289.52B | 0.13B | 0.12B | 0.07B | 0.05B | 2,968.81B | 0.02B | 0.05B | 0.02B | 0.02B | 0.02B | 0.14B | 0.21B | 0.20B | 0.20B | 0.18B | ||||||||||
| Asset Utilization RatioAsset Util. | 0.69 | 0.81 | 0.74 | 0.59 | 0.39 | 0.09 | 0.11 | |||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||
| Debt Ratio | 0.00B | 0.14 | 0.16 | 0.27 | 0.38 | 0.00B | 0.06 | 0.59 | 0.46 | 0.47 | 0.59 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | ||||||||||
| Times Interest Earned | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||
| Price to EarningsP/E | 26.50 | 16.14 | -17.24 | -12.24 | 22.10 | -16.35 | -5.24 | |||||||||||||||||||
| Price to SalesP/S | 19.64 | 9.34 | 104.36 | 62.73 | 39.63 | 23.81 | 16.57 | |||||||||||||||||||
| Price to BookP/B | 3.87 | 2.93 | 2.95 | 0.99 | 1.30 | 1.02 | 0.75 | 0.43 | 0.89 | 1.66 | 1.87 | 3.15 | 2.10 | 0.91 | 4.46 | 1.22 | 0.78 | 1.69 | 2.49 | 3.59 | ||||||
| Enterprise Value | 0.41B | 0.33B | 0.32B | 0.07B | 0.13B | 0.09B | 0.06B | 0.01B | 0.00B | 0.02B | 0.02B | 0.02B | 0.01B | 0.00B | 0.01B | 0.08B | 0.06B | 0.16B | 0.48B | 0.65B | ||||||
| EV to EBIT | 21.28 | 9.26 | -18.61 | -6.50 | -53.58 | -11.84 | -5.87 | |||||||||||||||||||
| EV to EBITDA | 21.28 | 9.26 | -18.61 | -6.50 | -53.58 | -11.84 | -5.87 | |||||||||||||||||||
| Market Capitalization | 0.54B | 0.48B | 0.38B | 0.12B | 0.16B | 0.12B | 0.08B | 0.02B | 0.02B | 0.03B | 0.04B | 0.04B | 0.02B | 0.01B | 0.02B | 0.17B | 0.16B | 0.34B | 0.49B | 0.65B | ||||||
| Return Ratios | ||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 69.75% | 69.88% | -481.96% | -582.97% | -57.92% | -156.61% | -226.40% | |||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 58.13% | 67.02% | 46.96% | 21.09% | 3.96% | -26.06% | -24.63% | |||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 0.00% | -21.19% | ||||||||||||||||||||||||
| Return on Assets [ROA]ROA | 42.44% | 48.77% | 33.06% | 13.71% | 3.56% | -19.56% | -17.35% |